Growth Metrics

Enanta Pharmaceuticals (ENTA) EBT Growth (1y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 12.59%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -148.28%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -313.33%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 71.54%
7 Evaxion A 62.56 Bn 62.54 Bn - -79.57%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -8.15%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 9,460.35%
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn - 45.37%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 45.37%
Dec 31, 2025 47.53%
Sep 30, 2025 36.04%
Jun 30, 2025 20.94%
Mar 31, 2025 24.02%
Dec 31, 2024 33.27%
Sep 30, 2024 1.12%
Jun 30, 2024 33.84%
Mar 31, 2024 16.20%
Dec 31, 2023 -17.26%
Sep 30, 2023 -12.09%
Jun 30, 2023 -8.39%
Mar 31, 2023 -11.97%
Dec 31, 2022 3.75%
Sep 30, 2022 21.14%
Jun 30, 2022 3.77%
Mar 31, 2022 -15.22%
Dec 31, 2021 -159.43%
Sep 30, 2021 -79.21%
Jun 30, 2021 -56.06%
Mar 31, 2021 -193.75%
Dec 31, 2020 -177.75%
Sep 30, 2020 -314.06%
Jun 30, 2020 -446.95%
Mar 31, 2020 -1,154.73%
Dec 31, 2019 -49.74%
Sep 30, 2019 -75.74%
Jun 30, 2019 -74.27%
Mar 31, 2019 -94.75%
Dec 31, 2018 93.92%
Sep 30, 2018 -34.71%
Jun 30, 2018 291.38%
Mar 31, 2018 300.12%
Dec 31, 2017 335.16%
Sep 30, 2017 2,191.13%
Jun 30, 2017 -1,851.56%
Mar 31, 2017 -9,531.18%
Dec 31, 2016 -118.16%
Sep 30, 2016 -162.83%
Jun 30, 2016 -132.26%
Mar 31, 2016 -100.19%
Dec 31, 2015 -49.05%
Sep 30, 2015 182.18%
Jun 30, 2015 -94.30%
Mar 31, 2015 1,037.36%
Dec 31, 2014 1,413.05%
Sep 30, 2014 -14.56%
Jun 30, 2014 944.15%
Mar 31, 2014 -31.29%
Dec 31, 2013 -124.48%
Sep 30, 2013 -9.57%
Jun 30, 2013 -18.91%
Mar 31, 2013 -112.34%